Translating FRESCO clinical trial evidence into practice: fruquintinib as post-standard third-line therapy followed by trifluridine/tipiracil in a patient with mCRC without targetable mutations [0.03%]
FRESCO临床研究证据应用于实践：一例无靶向突变的晚期结直肠癌患者使用呋喹替尼三线治疗后接受曲氟尿苷/替吡拉西四线治疗的案例报告
Tiago Biachi,Jessica Shostak
Tiago Biachi
Ravulizumab-danicopan combination therapy in PNH management [0.03%]
用于PNH管理的 ravulizumab 和 danicopan 联合治疗
Elizabeth A Griffiths
Elizabeth A Griffiths
What cancer patients may or may not be surprised to know about survivorship [0.03%]
关于癌症幸存者身份：病人可能知或不知的事实
John W Ragsdale,Kevin C Oeffinger,Celeste A Rousseau
John W Ragsdale
The number of US cancer survivors has increased from fewer than 4 million in the 1970s to 18.1 million in 2022, with the increase reflecting advancements in screening, diagnosis, treatment, and supportive care. Despite these advancements, c...
Rachel N Grisham
Rachel N Grisham
Jorge E Cortes
Jorge E Cortes
The diagnosis and treatment of red cell membrane disorders: algorithm for the general hematologist [0.03%]
红细胞膜病的诊断与治疗算法——给血液科医生
Theodosia A Kalfa
Theodosia A Kalfa
Unlocking the potential of patient-reported outcomes: practical uses in routine oncology care [0.03%]
释放患者报告结果的潜力——在肿瘤学常规护理中的实际应用
Roshan Paudel,Nadine J McCleary,Michael J Hassett et al.
Roshan Paudel et al.
A growing body of evidence supports the use of remote symptom monitoring based on patient-reported outcomes (PROs) to manage symptoms, improve quality of life, and reduce inpatient hospitalizations and emergency department visits. Health sy...
Dilan A Patel,Brad S Kahl
Dilan A Patel
Mantle cell lymphoma is a biologically and clinically heterogeneous subtype of non-Hodgkin lymphoma that affects predominantly older patients. The disease remains incurable with modern therapies. The integration of first- and now second-gen...
The use of PSMA PET/CT imaging as an endpoint in clinical trials of prostate cancer [0.03%]
PSMA PET/CT影像在前列腺癌临床试验中作为终点指标的应用
Michael J Morris
Michael J Morris